"I think this is a bull market still," Ed Yardeni says.» Read More
Baird says Biogen is off to a good start in sales of its new MS drug, with CNBC's Josh Lipton. Luiz Soares, Blackrock, discusses whether it's time to buy emerging markets.
With the PC market down 14 percent in Q1, how did Apple fare? CNBC's Jon Fortt reports.
Joe Terranova of Virtus Investment Partners explains why he remains cautious on the gold trade.
Caterpillar misses on Q1 earnings, revises 2013 outlook, and other top trades, with the FMHR crew.
Keith Meister, Corvex Management, weighs in on the Commonwealth takeover bid.
While stocks are likely to grind higher in the near term, it's unlikely the market will see a catalyst for the next leg higher, says Gemma Godfrey of Brooks MacDonald Asset Management.
CNBC Markets Reporter Josh Lipton investigates Google's eye-popping flash move -- a more than 3.5 percent stock price drop in the blink of an eye.
Despite some big earnings misses so far, a few companies tout positive factors for stocks, TheStreet CIO Stephanie Link says.
The major market indexes are all lower for the month of April, with the FMHR team and Gemma Godfrey, Brooks Macdonald.
CNBC's Simon Hobbs reports on Monday's market moving events in Europe, as shares pull back on weak earnings from Caterpillar.
Discussing the danger Boston bombings suspect Dzhokhar Tsarnaev may pose to the public and law enforcement officials, with Richard Hahn, counterterrorism & forensics explosives expert.
Boston Globe Reporter David Abel spoke with neighbors and the roommate of slain Patrol Officer Sean A. Collier.
The bears argue that we just keep blowing bubbles instead of taking our medicine and laying the framework for a lasting recovery.
The "Fast Money" traders share their final trades of the day.
Defensive sectors offer the best bets for investors, Gina Martin Adams of Wells Fargo says.
IBM into quarterly earnings should provide an important tell, Jon Najarian says.
The FMHR traders reveal their final trades.
The FMHR traders debate whether you should buy Chipotle.
Health care, consumer staples and utilities offer some of the best options for earnings growth, Gina Martin Adams of Wells Fargo says.
CNBC's Herb Greenberg says Intuitive Surgical has seen tremendous growth as the da Vinci robot is used more frequently in general surgeries.